Stock 300347 HANGZHOU TIGERMED CONSULTING CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

All News Hangzhou Tigermed Consulting Co., Ltd

Equities

300347

CNE100001KV8

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 25/04/2024 BST 		5-day change 1st Jan Change
57.7 CNY +8.85% Intraday chart for Hangzhou Tigermed Consulting Co., Ltd +16.24% +4.97%
04-25 Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 MT
04-25 Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hangzhou Tigermed Consulting’s Profit Down 59% in Q1
MT
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024
CI
Tigermed Consulting's Profit, Revenue Climb in 2023
MT
Hangzhou Tigermed Consulting Co., Ltd Announces Final Dividend for the Year Ended December 31, 2023, Payable on 31 July 2024
CI
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes
CI
China Healthcare Stocks Rally on Hopes for Government Support
DJ
China stocks steady, helped by biotech rally; Wuxi Apptec drags Hong Kong shares
RE
Nomura Downgrades Hangzhou Tigermed Consulting to Neutral From Buy, Adjusts Price Target to 49.61 Yuan From 75.72 Yuan
MT
Nomura Downgrades Tigermed to Neutral From Buy, Adjusts Price Target to HK$32.69 From HK$57.77
MT
Hangzhou Tigermed Consulting Plans Up to 1 Billion Yuan Share Repurchase; Shares Jump 4%
MT
Hangzhou Tigermed Consulting Co., Ltd announces an Equity Buyback for CNY 1,000 million worth of its shares.
CI
Hangzhou Tigermed Consulting Co., Ltd authorizes a Buyback Plan.
CI
Nomura Adjusts Hangzhou Tigermed Consulting' Price Target to 75.72 Yuan from 83.50 Yuan, Keeps at Buy
MT
Nomura Adjusts Hangzhou Tigermed Consulting' Price Target to HK$57.77 from HK$64.46, Keeps at Buy
MT
Hangzhou Tigermed Consulting's Profit Up 19% in Q3
MT
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tigermed Reports 2023 Interim Results
AQ
Tigermed Consulting's Profit Jumps 16.5% in H1
MT
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300347 Stock
  4. News Hangzhou Tigermed Consulting Co., Ltd